OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

Completed

Conditions studied: Liver Transplant

In brief

Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT CAP.

Key facts

Study ID

NCT05096754

Run by

TransMedics

People needed

74

Starts

2020-02-03

Expected to finish

2023-02-02

Last updated by the study team

2023-12-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects transplanted in the OCS Liver PROTECT CAP

Where it is running

• Scripps — La Jolla, California, United States
• University of California San Diego — La Jolla, California, United States
• University of California San Francisco — San Francisco, California, United States
• Johns Hopkins — Baltimore, Maryland, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• University of Nebraska Medical Center — Omaha, Nebraska, United States
• Mount Sinai — New York, New York, United States
• University of Texas Southwest — Dallas, Texas, United States
• Houston Methodist Hospital — Houston, Texas, United States
• The University of Texas Health Science Center at San Antonio — San Antonio, Texas, United States
• Virginia Commonwealth University Health System — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.